SCHEMBL4875955

SCHEMBL4875955

CCOC(=O)C(=O)CC=Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
PAM P19021 1/20 0.56
ALDH1A1 P00352 5/20 0.49
LMNA P02545 2/20 0.49
KDM4E B2RXH2 2/20 0.49
CTDSP1 Q9GZU7 1/20 0.49
MAOB P27338 2/20 0.47
RAB9A P51151 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NPC1 O15118 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PPARG P37231 1/20 0.46
MAPT P10636 2/20 0.46
MAOA P21397 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
HPGD P15428 1/20 0.46
XBP1 P17861 1/20 0.46
GRM4 Q14833 1/20 0.45
NR1H4 Q96RI1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4875949 1.00 MEN1 (0.58) MEN1KMT2APAMALDH1A1LMNA
SCHEMBL10891882 0.85 PAM (0.61) MEN1KMT2APAMALDH1A1LMNA
SCHEMBL10891880 0.85 PAM (0.61) MEN1KMT2APAMALDH1A1LMNA
SCHEMBL1792779 0.84 MEN1 (0.55) MEN1KMT2APAMALDH1A1LMNA
SCHEMBL7423208 0.79 HAO1 (0.63) MEN1KMT2AALDH1A1LMNAKDM4E
SCHEMBL7423204 0.79 HAO1 (0.63) MEN1KMT2AALDH1A1LMNAKDM4E
SCHEMBL7199351 0.79 MEN1 (0.49) MEN1KMT2APAMALDH1A1LMNA
SCHEMBL11015713 0.78 PAM (0.66) PAMALDH1A1LMNAMAOBL3MBTL1
SCHEMBL2705439 0.77 MEN1 (0.62) MEN1KMT2AALDH1A1LMNAKDM4E
SCHEMBL7060060 0.77 MEN1 (0.62) MEN1KMT2AALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465752-B2 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof MERCK PATENT GMBH (DE) 2008-12-16 US disclosed
US-20080015253-A1 Pentenoic Acid Derivatives, Processes For The Preparation Thereof, Pharmaceutical Compositions Comprising Them, And Therapeutic Applications Thereof MERCK PATENT GMBH (DE) 2008-01-17 US disclosed
EP-1742903-B1 PENTENOIC ACID DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, AND THERAPEUTIC APPLICATIONS THEREOF MERCK PATENT GMBH (DE) 2007-08-22 EP disclosed
EP-1742903-A1 PENTENOIC ACID DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, AND THERAPEUTIC APPLICATIONS THEREOF MERCK PATENT GmbH (DE) 2007-01-17 EP disclosed
WO-2005105723-A1 PENTENOIC ACID DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, AND THERAPEUTIC APPLICATIONS THEREOF MERCK PATENT GMBH (DE) 2005-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015253-A1 Pentenoic Acid Derivatives, Processes For The Preparation Thereof, Pharmaceutical Compositions Comprising Them, And Therapeutic Applications Thereof ALOX5, GPR119, ALOX15B MEN1 2567/4885KMT2A 4796/4885PAM 1282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.